Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus
Authors:
- A BoumaABA Bouma
- A.J de SmitASA.J de Smit
- E.P de KluijverEKE.P de Kluijver
- C TerpstraCTC Terpstra
- R.J.M MoormannRMR.J.M Moormann
- 1 April 1999
- journal article
- Published by Elsevier in Veterinary Microbiology
- Vol. 66 (2) , 101-114
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challengeJournal of General Virology, 1996
- An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccinesVeterinary Microbiology, 1996
- Potency control of modified live viral vaccines for veterinary useVaccine, 1996
- The use of marker vaccines in eradication of herpesvirusesJournal of Biotechnology, 1996
- Experimental quantification of vaccine-induced reduction in virus transmissionVaccine, 1994
- Recombinant polypeptide from the gp48 region of the bovine viral diarrhea virus (BVDV) detects serum antibodies in vaccinated and infected cattleVeterinary Microbiology, 1992
- An ELISA detecting antibody to conserved pestivirus epitopesJournal of Virological Methods, 1991
- Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's diseaseVeterinary Microbiology, 1990
- The protective value of vaccine-induced neutralising antibody titres in swine feverVeterinary Microbiology, 1988
- Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosisVeterinary Microbiology, 1986